Clinical Trial

Transcranial Magnetic Stimulation (rTMS) for Refractory Focal Epilepsy

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 8, 2024 (before its estimated February 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
Epilepsy as a brain disease is characterised by enhanced brain excitability. Low frequency repetitive transcranial magnetic stimulation (rTMS) can be an effective treatment for refractory focal epilepsy. Today different ways of stimulation were used, the best protocol of rTMS in refractory focal epilepsy is under evaluation. The aim of our study is neuropsychological and electrophysiological evaluation before and after rTMS sessions, the results of rTMS will be compared with VNS outcome in patients, who undergoes VNS implantation after rTMS.
Trial Details
NCT Number NCT06681480
Lead Sponsor Comenius University
Conditions Focal Epilepsy, Transcranial Magnetis Stimulation
Enrollment 20 participants
Start Date 2022-08-01
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-08